Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan
Open Access
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter studyAmerican Journal of Transplantation, 2022
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Recovery of physical function in lung transplant recipients with sarcopeniaBMC Pulmonary Medicine, 2021
- Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine ImmunizationPathogens, 2021
- MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)BMC Pulmonary Medicine, 2021
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Nature Immunology, 2020
- The fraction of sensitization among lung transplant recipients in a transplant center in JapanBMC Pulmonary Medicine, 2020
- Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant RecipientsTransplantation Direct, 2020
- The continuing story of T‐cell independent antibodiesImmunological Reviews, 2019
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012